Announcing the launch of BIO Integration a new fully open access journal

Shannon, February 18, 2020 — The publications division of Compuscript Ltd announces the launch of its newest open access journal, BIO Integration (BIOI); the journal represents a bold new step toward open science for the global medical community

Shannon, February 18, 2020 — The publications division of Compuscript Ltd announces the launch of its newest open access journal, BIO Integration (BIOI). The journal represents a bold new step toward open science for the global medical community.

The fully open access journal will allow for the rapid dissemination of multidisciplinary views driving the progress of modern medicine.

“We are beginning the decade with a commitment to providing an open-access platform to promote communication where scientific ideas and clinical needs can be identified, collaboratively explored, and ultimately solved.” Say the Co-Editors-in-Chief, Professor Zhiyi Chen, Guangzhou Medical University, China and Professor Pintong Huang, Zhejiang University, China. “BIOI will publish papers from around the world on clinical care, health policy, and global health across all medical and health-related disciplines.”

Scientific collaboration with industry is a major innovation driver in modern medical research, the long pathway from theoretical and technological innovation to clinical practice involves tremendous collaborative synergy. These collaborations are inevitably subject to challenges as interests, values, and aims often significantly differ between academia, clinicians and industry. A cross-disciplinary and multidirectional approach will increase the mutual awareness across the breadth of these communities and support the development of the next era of biomedical research.

Consequently, there is a need to build a high-quality interdisciplinary forum, and BIOI seeks to fill that niche. Aimed at bridging the gap between laboratories, clinics, and biotechnology industries, BIOI offers a cross-disciplinary platform devoted to communicating advances in the biomedical research field. Offering insights into different areas of life science. BIOI will encourage cooperation and discussion among scientists, clinical researchers and health care providers.

The name of “BIO Integration” comes from Chinese culture and philosophical thoughts of “harmony and cooperation”. “B” refers to biosciences which is the foundation of modern medicine; “I” refers to Intelligence; “O” reflects the ‘circle’ created through the integration of academic communities. It is the inevitable outcome of social development that new things come into being due to the integration of things. The word “integration” conveys multiple meanings. It can be the integration of different countries and races; it can be the integration of different academic circles and research fields; it can be the integration of multiple means and technologies, etc. The journal’s scope will be broad and dynamic, but always focused on supporting the advancement of biomedical science innovations from idea to practice, favouring papers that discuss theoretical and technological approaches to accelerating translational medical research.

As part of its mandate to help bring interesting work and knowledge from around the world to a wider audience, BIOI will actively support authors through open access publishing and through waiving author fees in its first years. Also, publication support for authors whose first language is not English will be offered in areas such as manuscript development, English language editing and artwork assistance.

###

BIOI is now open for submissions; articles can be submitted online at:

https://bio-integration.org/bioiojs/index.php/abs/about/submissions

Please visit http://www.bio-integration.org to learn more about the journal.

Editorial Board: https://bio-integration.org/editorial-board/

BIOI is available at Bio Integration. Submissions may be made using OJS. There are no author submission or article processing fees.

Twitter: @JournalBio Facebook: BIO Integration

ISSN 2712-0074

eISSN 2712-0082

Media Contact
Morgan Lyons
[email protected]

Comments